Paloma Partners Management CO Pacira Bio Sciences, Inc. Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $198,082 - $253,717	7,151 New	7,151 $208,000
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $227,720 - $298,965	-4,512 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $16,838 - $20,412	324 Added 7.74%	4,512 $271,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $128,990 - $219,744	4,188 New	4,188 $220,000
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $210,350 - $275,923	-5,752 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $209,775 - $242,561	5,752 New	5,752 $219,000
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $296,891 - $459,004	-9,903 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $315,410 - $464,945	9,903	9,903 $452,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.